Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.
Expanded Access requests from treating physicians may be submitted at www.pfizercares.com; availability will depend on location/country.
Must have ≥ 50% hair loss on scalp due to Alopecia Areata (AA) and be intolerant or have
inadequate response to all commonly used AA therapies accessible in the country. Additional
eligibility criteria may be required.